References
Delbet JD, Leclerc G, Ulinski T (2019) Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery? Pediatr Nephrol 34:529–532
Kamei K, Takahashi M, Fuyama M, Saida K, Machida H, Sato M, Ogura M, Ito S (2015) Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature. Nephrol Dial Transplant 30:91–96
Dunleavy K, Tay K, Wilson WH (2010) Rituximab-associated neutropenia. Semin Hematol 47:180–186
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fujinaga, S., Tomii, Y. Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 34, 1303–1304 (2019). https://doi.org/10.1007/s00467-019-04235-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04235-5